P273 EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH RISK HYPERCHOLESTEROLEMIC PATIENTS STRATIFIED BY PRIOR STATIN TREATMENT POTENCY

Autor:	M. Viigimaa, H. Vaverkova, M. Farnier, M. Averna, L. Missault, Q. Dong, A. Shah, M. Hanson, P. Brudi
Rok vydání:	2010
Předmět:	Internal Medicine General Medicine Cardiology and Cardiovascular Medicine
Zdroj:	Atherosclerosis Supplements. 11:74
ISSN:	1567-5688
DOI:	10.1016/s1567-5688(10)70340-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::178328516b3b1a13a1f2b44bb2861710 https://doi.org/10.1016/s1567-5688(10)70340-8 Zobrazit plný text záznamu Full Text from ScienceDirect